Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Five-Year Survival Less Than 40 Percent in Seniors With DLBCL

drugsJuly 01, 2019

Tag: DLBCL , survival , Seniors

PharmaSources Customer Service